Adiuvo Investments S.A.

Equities

ADV

PLADVIV00015

Investment Management & Fund Operators

Delayed Warsaw S.E. Other stock markets 05:41:18 26/06/2024 pm IST			5-day change	1st Jan Change
0.32 ^PLN	-21.95%		-41.82%	-64.04%

31/05	Adiuvo Investments S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02/05	Adiuvo Investments S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Adiuvo Investments S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024

May 01, 2024 at 03:24 am IST

Adiuvo Investments S.A. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was PLN 0.305 million compared to negative sales of PLN 0.044 million a year ago. Net loss was PLN 1.08 million compared to PLN 0.331 million a year ago.

Latest news about Adiuvo Investments S.A.

Adiuvo Investments S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	01/06	CI
Adiuvo Investments S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	02/05	CI
Adiuvo Investments S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30/11	CI
Adiuvo Investments S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	03/23/03	CI
Adiuvo Investments S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	31/23/31	CI
Adiuvo Investments S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	29/23/29	CI
Adiuvo Investments S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	29/23/29	CI
Adiuvo Investments S.A. Auditor Raises 'Going Concern' Doubt	29/23/29	CI
Adiuvo Investments S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29/22/29	CI
Adiuvo Investments S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	24/22/24	CI
Adiuvo Investments S.A. Auditor Raises 'Going Concern' Doubt	30/22/30	CI
Adiuvo Investments S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	24/22/24	CI
Adiuvo Investments S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	03/22/03	CI
Adiuvo Investments S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	30/21/30	CI
Adiuvo Investments S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021	01/21/01	CI
Adiuvo Investments S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	25/21/25	CI
Marek Orlowski, Orenore Sp. z o.o. and Morluk Sp. z o.o. sp.k. signed a preliminary agreement to acquire additional unknown stake in Adiuvo Investments S.A. from Boguslaw Bobula, Maciej Zajac and Aleksandra Siegenthaler.	01/21/01	CI
Adiuvo Investments S.A. announced that it has received funding	17/19/17	CI
Adiuvo Investments S.A. announced that it has received PLN 4.17 million in funding	24/19/24	CI
Adiuvo Investments S.A. announced that it expects to receive PLN 4.17 million in funding	20/18/20	CI
Adiuvo Investments S.A.'s Equity Buyback announced on March 17, 2017, has expired.	16/18/16	CI
Adiuvo Investments S.A. announced that it expects to receive PLN 0.1 million in funding	27/17/27	CI
Adiuvo Investments S.A.(WSE:ADV) dropped from WIG 20 Index	20/17/20	CI
Adiuvo Investments S.A.(WSE:ADV) added to WIG 20 Index	13/17/13	CI
Adiuvo Investments S.A. announces an Equity Buyback for 2,500,000 shares, representing 21.1% for PLN 147.63 million.	17/17/17	CI

Chart Adiuvo Investments S.A.

Duration

Period

More charts

Company Profile

Adiuvo Investments SA is a Poland-based company engaged in the financial industry. The Company focuses on the selection, development, financing and commercialization of biomedical projects on the international market. By providing intellectual property protection, technology validation in clinical trials and obtaining certificates allowing products to market, Adiuvo Investments SA is able to commercialize projects in diverse business model and internationally. The Company is looking for and invests in projects in the segments of the nutraceutical, medical devices and the digital health. Its business portfolio encompasses Airway Medix, Algae Labs, Carocelle, Cambridge Chocolate Technology, Endomedical, Esthechoc, Glia, Joint Polish Investment Fund, Marmar Investment, Nanoxide and Peptaderm.

Sector

Investment Management & Fund Operators

More about the company

Income Statement Evolution

More financial data

Sector Venture Capital

	1st Jan change	Capi.
ADIUVO INVESTMENTS S.A.	-64.04%	1.34M
HERCULES CAPITAL, INC.	+20.22%	3.2B
UMBRA COMPANIES INC.	+12.50%	1.76B
HBM HEALTHCARE INVESTMENTS AG	+12.54%	1.59B
OCTOPUS TITAN VCT PLC	-11.54%	1.22B
MOLTEN VENTURES PLC	+33.83%	906M
CION INVESTMENT CORPORATION	+7.25%	650M
VERUSA HOLDING	+53.68%	603M
OCTOPUS APOLLO VCT PLC	-4.78%	504M
WOORI TECHNOLOGY INVESTMENT CO., LTD	+19.25%	435M

Venture Capital